CID is 3475
synonyms found at PubChem are:
gliclazide, 21187-98-4, Glimicron, Diamicron, Nordialex, Diaikron, Gliclazida, Gliklazid, Glyclazide, Gliclazidum [INN-Latin], Gliclazida [INN-Spanish], Gliclazidum, Glimicron (TN), 1-(3-Azabicyclo[3.3.0]oct-3-yl)-3-p-tolylsulphonylurea, 1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea, C15H21N3O3S, CHEBI:31654, 1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea, S 1702, N-(hexahydrocyclopenta[c]pyrrol-2(1H)-ylcarbamoyl)-4-methylbenzenesulfonamide, S 852, S-852, Gliclazide [BAN:INN:DCF:JAN], S-1702, N-(4-Methylbenzenesulfonyl)-N'-(3-azabicyclo(3.3.0)oct-3-yl)urea, 1-(3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl)-3-(4-methylphenyl)sulfonylurea, SE 1702, SE-1702, DSSTox_CID_3095, DSSTox_RID_76872, DSSTox_GSID_23095, 1-[3-Azabicyclo[3.3.0]oct-3-yl]-3-p-toluenesulfonylurea, Diabrezide, 1-(3-azabicyclo[3.3.0]oct-3-yl)-3-(p-tolylsulfonyl)urea, Benzenesulfonamide, N-(((hexahydrocyclopenta(c)pyrrol-2(1H)-yl)amino)carbonyl)-4-methyl-, N-((hexahydrocyclopenta[c]pyrrol-2(1H)-yl)carbamoyl)-4-methylbenzenesulfonamide, N-[(hexahydrocyclopenta[c]pyrrol-2(1H)-ylamino)carbonyl]-4-methylbenzenesulfonamide, SMR000542971, SR-01000816184, diabezidum, diabyl, diaprel, dizalid, gliclazid, glinormax, glyzide, EINECS 244-260-5, Mylan-Gliclazide, Diamicron MR, PMS-Gliclazide, Urea, 1-(hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)-, Urea, 1-(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)-, Benzenesulfonamide, N-[[(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)amino]carbonyl]-4-methyl-, Gliclazide,(S), BRN 1657836, Diamicron (TN), NCGC00016751-01, Prestwick_869, Dianorm (TN), CAS-21187-98-4, Glubitor-OD (TN), Gliclazide (Diamicron), Spectrum_001478, SpecPlus_000870, Gliclazide (JAN/INN), Prestwick0_000558, Prestwick1_000558, Prestwick2_000558, Prestwick3_000558, Spectrum3_001862, Spectrum4_000598, Spectrum5_000753, D0M2MR, Gliclazide (JP17/INN), AC1L1G0Q, SCHEMBL16387, BSPBio_000635, BSPBio_003304, KBioGR_001096, KBioSS_001958, MLS001215197, MLS001304077, MLS001304118, DivK1c_006966, Gliclazide, powder, >=98%, SPECTRUM1504145, SPECTRUM1505013, SPBio_002556, BPBio1_000699, CHEMBL427216, DTXSID9023095, CTK7G8576, KBio1_001910, KBio2_001958, KBio2_004526, KBio2_007094, KBio3_002806, BOVGTQGAOIONJV-UHFFFAOYSA-N, MolPort-002-507-779, HMS1569P17, HMS1922D15, HMS2090K16, HMS2096P17, HMS2855P09, HMS3656C22, HMS3713P17, Pharmakon1600-01504145, BCP21240, HY-B0753, Tox21_110590, ANW-43362, BBL012275, BDBM50103512, BG0208, MFCD00409893, NSC758673, s2601, SBB066074, STK803142, AKOS003237903, AKOS016340698, Tox21_110590_1, AB05958, API0002840, CCG-213918, CS-2963, DB01120, KS-1067, MCULE-7993816491, NSC-758673, RP17658, NCGC00095107-01, NCGC00095107-02, NCGC00095107-03, NCGC00095107-04, NCGC00095107-05, NCGC00095107-06, NCGC00095107-09, NCGC00095107-10, AC-12045, AN-17308, ST076805, SBI-0052662.P002, AB0012093, AB1004595, LS-160299, AB00053165, FT-0626712, G0381, D01599, K-6100, AB00053165-09, AB00053165_10, AB00053165_11, 187G984, A815188, I06-0117, J-013905, J-522753, SR-01000816184-2, SR-01000816184-3, SR-01000816184-4, BRD-A61154809-001-04-3, Gliclazide, British Pharmacopoeia (BP) Reference Standard, Gliclazide, European Pharmacopoeia (EP) Reference Standard, 1-[(4-methylbenzene)sulfonyl]-3-{octahydrocyclopenta[c]pyrrol-2-yl}urea, 3-{hexahydro-1H-cyclopenta[c]pyrrol-2-yl}-1-(4-methylbenzenesulfonyl)urea, [(3-azabicyclo[3.3.0]oct-3-yl)amino]-N-[(4-methylphenyl)sulfonyl]carboxamide, 1-(3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl)-3-(4-methylphenyl)sulfonyl-urea, 1-(3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl)-3-(p-tolylsulfonyl)urea, 2-(((((4-ME-PHENYL)SULFONYL)AMINO)CARBONYL)AMINO)OCTAHYDROCYCLOPENTA(C)PYRROLE, Benzenesulfonamide,N-[[(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)amino]carbonyl]-4-methyl-, N-(3-azabicyclo[3.3.0]oct-3-yl){[(4-methylphenyl)sulfonyl]amino}carboxamide, N-[[(HEXAHYDROCYLOPENTA[C]PYRROL-2(1H)-YL)AMINO]CARBONYL]-4-METHYLBENZENESULFONAMIDE, BENZENESULFONAMIDE, N-[[(HEXAHYDROCYCLOPENTA[C]PYRROL-2(1H)-YL)AMINO]CARBONYL]-4-METHYL